Neuroprotection of the nigrostriatal dopaminergic neurons by melatonin in hemiparkinsonium rat

Indian Journal of Medical Research

Volumn 124, Issue OCT., 2006, Pages 419-426

  Singh, S ^a   Ahmed, R ^a   Sagar, R K ^a   Krishana, Bal ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

6 hydroxydopamine; Melatonin; Parkinson's disease

Indexed keywords

APOMORPHINE; MELATONIN; OXIDOPAMINE; SODIUM CHLORIDE; DOPAMINE; NEUROPROTECTIVE AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY EQUILIBRIUM; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; RAT; STATISTICAL SIGNIFICANCE; ANIMAL; DRUG EFFECT; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT; VISUAL CORTEX;

ANIMALS; DOPAMINE; FEMALE; MELATONIN; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; VISUAL CORTEX;

EID: 34247204351     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Agid Y, Chase T, Marsden D. Adverse reaction to levodopa drug toxicity or progression of disease. Lancet 1998; 351: 851-2.
2. Tan DX, Poeggeler B, Reiter RJ, Chen CD, Chen S, Manchester LC, et al. The pineal hormone melatonin inhibits DNA adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 1993; 70: 65-71.
3. Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56: 359-84.
4. Akcay YD, Yalcin A, Sozmen EY. The effect of melatonin on lipid peroxidation and nitrite/nitrate levels, and on superoxide dismutase and catalase activities in kainic acid-induced injury. Cell Mol Biol Lett 2005; 10: 321-9.
5. Baydas G, Ozveren F, Akdemir I, Tuzcu M, Yasar A. Learning and memory deficits in rats induced by chronic thinner exposure are reversed by melatonin. J Pineal Res 2005; 39: 50-6.
6. Wu YH, Swaab DF. The human pineal gland and melatonin in aging and Alzheimer's disease. J Pineal Res 2005; 38: 145-52.
7. Leon J, Castroviejo DA, Escames G, Tan DX, Reiter RJ. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005; 38: 1-9.
8. Shida CS, Castrucci AMI, Lamy-Freund MT. High melatonin solubility in aqueous medium. J Pineal Res 1994; 16: 198-201.
9. Costa EJX, Lopez RH, Lamy-Freund MT. Permeability of pure lipid bilayers to melatonin. J Pineal Res 1995; 19: 123-6.
10. Reiter RJ. Melatonin: that ubiquitously acting pineal hormone. New Physiol Sci 1991; 6: 223-7.
11. Menendez-Pelaez A, Poeggeler B, Reiter RJ, Barlow-Walden LR, Pablos MI, Tan DX. Nuclear localizations of melatonin in different mammalian tissues: immunocytochemical and radioimmunossay evidence. J Cell Biochem 1993; 53: 373-82.
12. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. Sydney, Australia: Academic Press; 1986.
13. Ungerstedt U, Arbuthnott GW. Quantitive recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 1970; 24: 485-93.
14. Montoya CP, Campbell-Hope LJ, Pemberton KD, Dunnett SB. The "Staircase test": a measure of independent forelimb reaching and grasping abilities in rats. J Neurosci Methods 1991; 36: 219-28.
15. Schallert T, Ryck MD, Whishaw IQ, Ramirez VD, Teitelbaum P. Excessive bracing reactions and their control by atropine and L-dopa in an animal analog of parkinsonism. Exp Neurol 1979; 64: 33-43.
16. Olsson M, Nikkhah G, Bentlage C, Bjorklund A. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 1995; 15: 3863-75.
17. Winkler C, Sauer H, Lee CS, Bjorklund A. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci 1996; 16: 7206-15.
18. Sauer H, Oertel WH. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 1994; 59: 401-15.
19. Sala FD, Santo SD, Franceschini D, Skaperr SD, Giusti P. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J 2001; 15: 164-70.
20. Mayo JC, Sainz RM, Uria H, Antolin I, Esteban MM, Rodriguez C. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease. J Pineal Res 1998; 24: 179-92.
21. Anton-Tay F, Diaz JL, Fernandez-Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sci 1971; 10: 841-50.
22. Shaw KM, Stern GM, Sandler M. Melatonin and parkinsonism. Lancet 1973; 1: 271-9.
23. Willis GL, Armstrong SM. A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease. Physiol Behav 1999; 66: 785-95.
24. Guarduika-Lemaitre B. Toxicology of melationin. J Biol Rhythms 1997; 12: 697-706.
25. Willis GL, McLennan CA. Pinealectomy and dopamine replacement therapy in models of Parkinson's disease. A satellite symposium of the 34th International congress of physiological sciences on the theme melatonin and biological rhythms; 2001 p. 10.
26. Aguiar LMV, Vasconcelos SMM, Sousa FCF, Viana GSB. Melatonin reverses neurochemical alterations induced by 6-OHDA in rat striatum. Life Sci 2002; 70: 1041-51.
27. Mayo JC, Sainz RM, Antolin I, Rodriguez C. Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage. Brain Res 1999; 13: 221-7.
28. Joo WS, Jin BK, Park CW, Maeng SH, Kim YS. Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats. Neuroreport 1998; 9: 4123-6.
29. Kumar R, Agarwal AK, Seth PK. Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem 1995; 64: 1703-7. Erratum in: J Neurochem 1995; 65: 1906.
30. Zapico T, Montes C. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005; 39: 99-104.